Estudio del patrón de metilación génico en el cáncer gástrico en Chile

Background:Promoter genomic DNA methylation is an important inactivation mechanism of tumor suppressor genes. This genetic-molecular pathway for cancer may separate a subset of patients with different prognoses and eventually different responses to specific therapies. Aim: To analyze the methylation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Roa S,Juan Carlos, Anabalón R,Leonardo, Roa E,Iván, Tapia E,Oscar, Melo,Angélica, Villaseca H,Miguel, Araya O,Juan Carlos
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2005
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000800002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872005000800002
record_format dspace
spelling oai:scielo:S0034-988720050008000022014-08-12Estudio del patrón de metilación génico en el cáncer gástrico en ChileRoa S,Juan CarlosAnabalón R,LeonardoRoa E,IvánTapia E,OscarMelo,AngélicaVillaseca H,MiguelAraya O,Juan Carlos DNA methylation Promoter regions (Genetics) Stomach neoplasms Background:Promoter genomic DNA methylation is an important inactivation mechanism of tumor suppressor genes. This genetic-molecular pathway for cancer may separate a subset of patients with different prognoses and eventually different responses to specific therapies. Aim: To analyze the methylation pattern of important genes related to different carcinogenic mechanisms in patients with gastric cancer (GC) and the relationship with its morphological features and biological behavior. Material and methods: Forty-seven fresh-frozen GC samples were selected. The methylation-specific PCR (MSP) test was used to analyze promoter methylation status for genes MLH1, CDKN2A (p16), APC, CDH1 (Cadherin E) and FHIT. Follow-up and complete morphological features were obtained for all cases. Results: We found methylation in at least one of the genes studied in 83% of the cases. The frequencies of promoter hypermethylation of MLH1, CDKN2A, APC, CDH1 and FHIT were 31%, 43%, 46%, 80% y 62%, respectively. We found a relationship between APC methylation and good histological differentiation (p=0.03); CDH1 methylation with diffuse type by Lauren and 3 or more metastasic lymph nodes (p <0.05); FHIT, CDKN2A and CDH1 methylation and female condition (p <0.04). We also found a non-significant relationship between CDKN2A methylation and better survival (p=0.07). Conclusions: The high frequency promoter methylation found confirms its importance in gastric carcinogenesis. The finding of alterations in the methylation pattern of genes studied and its association with prognostic factors is a helpful tool in the search for new criteria in clinical and therapeutic decision makinginfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.133 n.8 20052005-08-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000800002es10.4067/S0034-98872005000800002
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic DNA methylation
Promoter regions (Genetics)
Stomach neoplasms
spellingShingle DNA methylation
Promoter regions (Genetics)
Stomach neoplasms
Roa S,Juan Carlos
Anabalón R,Leonardo
Roa E,Iván
Tapia E,Oscar
Melo,Angélica
Villaseca H,Miguel
Araya O,Juan Carlos
Estudio del patrón de metilación génico en el cáncer gástrico en Chile
description Background:Promoter genomic DNA methylation is an important inactivation mechanism of tumor suppressor genes. This genetic-molecular pathway for cancer may separate a subset of patients with different prognoses and eventually different responses to specific therapies. Aim: To analyze the methylation pattern of important genes related to different carcinogenic mechanisms in patients with gastric cancer (GC) and the relationship with its morphological features and biological behavior. Material and methods: Forty-seven fresh-frozen GC samples were selected. The methylation-specific PCR (MSP) test was used to analyze promoter methylation status for genes MLH1, CDKN2A (p16), APC, CDH1 (Cadherin E) and FHIT. Follow-up and complete morphological features were obtained for all cases. Results: We found methylation in at least one of the genes studied in 83% of the cases. The frequencies of promoter hypermethylation of MLH1, CDKN2A, APC, CDH1 and FHIT were 31%, 43%, 46%, 80% y 62%, respectively. We found a relationship between APC methylation and good histological differentiation (p=0.03); CDH1 methylation with diffuse type by Lauren and 3 or more metastasic lymph nodes (p <0.05); FHIT, CDKN2A and CDH1 methylation and female condition (p <0.04). We also found a non-significant relationship between CDKN2A methylation and better survival (p=0.07). Conclusions: The high frequency promoter methylation found confirms its importance in gastric carcinogenesis. The finding of alterations in the methylation pattern of genes studied and its association with prognostic factors is a helpful tool in the search for new criteria in clinical and therapeutic decision making
author Roa S,Juan Carlos
Anabalón R,Leonardo
Roa E,Iván
Tapia E,Oscar
Melo,Angélica
Villaseca H,Miguel
Araya O,Juan Carlos
author_facet Roa S,Juan Carlos
Anabalón R,Leonardo
Roa E,Iván
Tapia E,Oscar
Melo,Angélica
Villaseca H,Miguel
Araya O,Juan Carlos
author_sort Roa S,Juan Carlos
title Estudio del patrón de metilación génico en el cáncer gástrico en Chile
title_short Estudio del patrón de metilación génico en el cáncer gástrico en Chile
title_full Estudio del patrón de metilación génico en el cáncer gástrico en Chile
title_fullStr Estudio del patrón de metilación génico en el cáncer gástrico en Chile
title_full_unstemmed Estudio del patrón de metilación génico en el cáncer gástrico en Chile
title_sort estudio del patrón de metilación génico en el cáncer gástrico en chile
publisher Sociedad Médica de Santiago
publishDate 2005
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000800002
work_keys_str_mv AT roasjuancarlos estudiodelpatrondemetilaciongenicoenelcancergastricoenchile
AT anabalonrleonardo estudiodelpatrondemetilaciongenicoenelcancergastricoenchile
AT roaeivan estudiodelpatrondemetilaciongenicoenelcancergastricoenchile
AT tapiaeoscar estudiodelpatrondemetilaciongenicoenelcancergastricoenchile
AT meloangelica estudiodelpatrondemetilaciongenicoenelcancergastricoenchile
AT villasecahmiguel estudiodelpatrondemetilaciongenicoenelcancergastricoenchile
AT arayaojuancarlos estudiodelpatrondemetilaciongenicoenelcancergastricoenchile
_version_ 1718436216991383552